Filing metadata

Accession number
0001628280-20-014242
Form type
Form 4
Filer
Revance Therapeutics, Inc.
CIK
CIK 1479290
Filed
Oct 02, 2020
Reporting period
Sep 30, 2020
Description
Insider transaction

Explore SEC Filings Hub